Type 1 immune response in progressive multiple sclerosis

Journal of Neuroimmunology

Volumn 249, Issue 1-2, 2012, Pages 112-116

  Frisullo, Giovanni ^a   Plantone, Domenico ^a   Marti, Alessandro ^a   Iorio, Raffaele ^a   Damato, Valentina ^a   Nociti, Viviana ^b   Patanella, Agata Katia ^b   Bianco, Assunta ^a   Batocchi, Anna Paola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Multiple sclerosis; PPMS; SPMS; T bet; Transcription factor

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; TRANSCRIPTION FACTOR T BET;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TC1 CELL; TH1 CELL; TYPE 1 IMMUNE RESPONSE;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; SEVERITY OF ILLNESS INDEX; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 84863492497     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.04.019     Document Type: Article

References (24)

1. Balashov K.E., Smith D.R., Khoury S.J., Hafler D.A., Weiner H.L. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(2):599-603.
2. Balashov K.E., Comabella M., Ohashi T., Khoury S.J., Weiner H.L. Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS. Neurology 2000, 55(2):192-198.
3. Becher B., Giacomini P.S., Pelletier D., McCrea E., Prat A., Antel J.P. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Ann. Neurol. 1999, 45(2):247-250.
4. Frischer J.M., Bramow S., Dal-Bianco A., Lucchinetti C.F., Rauschka H., Schmidbauer M., Laursen H., Sorensen P.S., Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132:1175-1189.
5. Frisullo G., Angelucci F., Caggiula M., Nociti V., Iorio R., Patanella A.K., Sancricca C., Mirabella M., Tonali P.A., Batocchi A.P. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 2006, 84(5):1027-1036.
6. Frisullo G., Nociti V., Iorio R., Patanella A.K., Bianco A., Caggiula M., Sancricca C., Tonali P.A., Mirabella M., Batocchi A.P. Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. Clin. Immunol. 2007, 124(3):284-293.
7. Harris D.P., Goodrich S., Gerth A.J., Peng S.L., Lund F.E. Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor. J. Immunol. 2005, 174(11):6781-6790.
8. Ingle G.T., Stevenson V.L., Miller D.H., Thompson A.J. Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 2003, 126(11):2528-2536.
9. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Brück W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J.E., Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
10. Lassmann H. Clinical and pathological topics of multiple sclerosis. Rinsho Shinkeigaku 2009, 49(11):715-718.
11. Lassmann H., Brück W., Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007, 17(2):210-218.
12. Lord G.M., Rao R.M., Choe H., Sullivan B.M., Lichtman A.H., Luscinskas F.W., Glimcher L.H. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 2005, 106(10):3432-3439.
13. Lucchinetti C.F., Parisi J., Bruck W. The pathology of multiple sclerosis. Neurol. Clin. 2005, 23(1):77-105.
14. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130(4):1089-1104.
15. Mullen A.C., High F.A., Hutchins A.S., Lee H.W., Villarino A.V., Livingston D.M., Kung A.L., Cereb N., Yao T.P., Yang S.Y., Reiner S.L. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001, 292(5523):1907-1910.
16. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N Engl J Med. 2000, 343(13):938-952. Sep 28.
17. Popescu B.F., Lucchinetti C.F. Pathology of demyelinating diseases. Annu. Rev. Pathol. 2012, 7:185-217.
18. Prat A., Pelletier D., Duquette P., Arnold D.L., Antel J.P. Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume. Ann. Neurol. 2000, 47(2):234-237.
19. Rovaris M., Bozzali M., Santuccio G., Ghezzi A., Caputo D., Montanari E., Bertolotto A., Bergamaschi R., Capra R., Mancardi G., Martinelli V., Comi G., Filippi M. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001, 124(12):2540-2549.
20. Soldan S.S., Alvarez Retuerto A.I., Sicotte N.L., Voskuhl R.R. Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis. J. Neuroimmunol. 2004, 146(1-2):209-215.
21. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100(6):655-669.
22. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., Glimcher L.H. Distinct effects of T-bet in Th1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 2002, 295:338-342.
23. Thieu V.T., Yu Q., Chang H.C., Yeh N., Nguyen E.T., Sehra S., Kaplan M.H. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 2008, 29(5):679-690.
24. Van Boxel-Dezaire A.H., Hoff S.C., van Oosten B.W., Verweij C.L., Dräger A.M., Adèr H.J., van Houwelingen J.C., Barkhof F., Polman C.H., Nagelkerken L. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 1999, 45(6):695-703.